Transcranial Focused Ultrasound for Depression and Anxiety

Palo Alto (17 mi)

Dr. Sheldon Jordan | Neurologist | Los ...

Overseen bySheldon Jordan, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: Neurological Associates of West Los Angeles

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this open label study is to evaluate longer term tolerability and early efficacy of transcranial ultrasound in the treatment of patients with refractory depression and anxiety.

Eligibility Criteria

This trial is for adults who have tried at least three antidepressants and anxiolytics without improvement, have a diagnosis of Major Depressive Disorder or Generalized/Acute Anxiety Disorder, and score high on anxiety and depression scales.

Inclusion Criteria

I am 18 years old or older.

I have tried 3 different anxiety medications without success.

I have tried 3 antidepressants without success.

I have been diagnosed with Major Depressive Disorder.

I have been diagnosed with Generalized or Acute Anxiety Disorder.

Treatment Details

The study is testing the use of transcranial focused ultrasound as a treatment. It's an open label study, meaning everyone knows they're getting the treatment, to see if it helps with severe depression and anxiety.

1Treatment groups

Experimental Treatment

Group I: TreatmentExperimental Treatment1 Intervention

All patients enrolled will receive transcranial focused ultrasound. Target location is dependent on patient condition.